Market Pulse59Neutral

Doximity, Inc.Opportunity Rank #62(DOCS) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$26.03

Last updated: May 08, 2026

Price vs Intrinsic Value

$26.03
Price
$53.28
Intrinsic Value
Undervalued by 105%MOS: $42.62

Fundamental Score

98/100
Bullish

Weighted across 6 signals

Narrative Score

52/100
Weak

No change vs previous

Trend Score

34/100
Weak

As of 2026-05-08

The intrinsic value of Doximity, Inc. (DOCS) is estimated at $53.28 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $26.03, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 15.81% long-term growth rate and a 10.11% discount rate, reflecting expected future free cash flow and cost of capital.

The intrinsic value of Doximity, Inc. (DOCS) is estimated at $53.28 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $26.03, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 15.81% long-term growth rate and a 10.11% discount rate, reflecting expected future free cash flow and cost of capital.

Valuation Details

$53.28
▲ 104.69% upside
20% margin of safety: $42.62
Years: 10Growth Rate: 15.81%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
27.77%
Cost of Capital (estimated)7%
Value StatusCreating Value

The company is earning a higher return on invested capital than it costs to raise that capital — a sign of strong, efficient value creation.

Complete historical ROIC is available with
.

Fundamental Details

98/100
BullishWeighted across 6 signals
DCF Discount
104.7% discount to price
100
FCF Yield
6.5% trailing FCF yield
100
ROIC vs WACC
ROIC 27.8% vs WACC 7.0% (4.0x)
100
Net Debt / FCF
Net cash position
100
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
60.0% 5Y FCF CAGR
100
Strengths lead the score: DCF Discount, FCF Yield.

Narrative Details

52/100
Weak
Vs 6-Month Baseline:Average (52nd pct)Weighted across 5 recent drivers
Trend: StableConfidence: 88%Updated: 16h ago
Sources: 35 (23 News · 12 Analyst)
Drivers(last 30 days)
4 regulatory scrutiny+0.4
19 news sentiment-0.1
2 analyst downgrades-0.1
Analyst upgrades+0.0
9 analyst reiterations0.0

Trend Details

34/100
WeakAs of 2026-05-08311 daily bars used
Distance from 52-Week High-65.4%
6M Relative Strength vs SPY-68.3%
3M Relative Strength vs SPY-13.1%
Price vs 21 EMA78 · +5.3%
Price vs 50 EMA51 · +0.3%
21 EMA vs 50 EMA17 · -4.7%
3M RS vs SPY10 · -13.1%
6M RS vs SPY0 · -68.3%
Distance from 52W High0 · -65.4%

Investment Coach

Updating... 1d ago
BUYConfidence: 81%
Thesis
Doximity, Inc. (DOCS) is significantly undervalued with an estimated fair value nearly 95% above its current price, supported by a strong fundamental score of 98 and a robust ROIC that exceeds its cost of capital by over 20 points. The company also demonstrates healthy free cash flow yield and consistent buybacks, indicating strong financial health and growth potential.
Key Risk
A key risk is any deterioration in the company's ROIC relative to its cost of capital, which could undermine its valuation premium.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Confirm ROIC stays above cost of capital over coming quarters.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 26.47%5 Year CAGR: 29.53%

Free Cash Flow (in millions)

TTM2025202420232022202120202019
$319$280$190$186$132$88$30$16

How Intrinziq Estimates Fair Value

Intrinziq estimates Doximity, Inc.'s intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Doximity, Inc.Healthcare

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.